Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Younesi, Saranga | Mahdi Taheri Amin, Mohammada | Saadati, Pourandokhta | Yazdani, Baharehb | Jamali, Soudabeha | Modarresi, Mohammad-Hosseinc | Savad, Shahramc | Amidi, Saloomeha | Ghafouri-Fard, Soudehd; * | Razmpoosh, Elhame; f | Yazarlou, Fatemehc; *
Affiliations: [a] Prenatal Screening Department of Nilou Laboratory, Tehran, Iran | [b] Neonatal Screening Department of Nilou Laboratory, Tehran, Iran | [c] Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran | [d] Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran | [e] Nutrition and Food Security Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran | [f] Quality of Life Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran
Correspondence: [*] Corresponding authors: Soudeh Ghafouri-Fard, Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran. E-mail: s.ghafourifard@sbmu.ac.ir; Fatemeh Yazarlou, Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Tel.: +21 2387 2572; E-mail: f_yazarlou@alumnus.tums.ac.ir.
Abstract: OBJECTIVES: To evaluate the performance of the current national screening policy for Down syndrome (DS) in Iran and suggest a more efficient protocol with a wealth of a large series of first-trimester screening (FTS) data obtained from Nilou medical laboratory. To fulfill this aim, detection rate (DR), positive screening rate (PSR), false negative rate (FNR) and odds of being affected given a positive results (OAPR) were calculated at different cutoff risk. In the latest update of DS screening program in Iran, there is no place for intermediate group to be further investigated. Next, we proposed a novel parameter namely the ratio of fβ-hCG multiple of the median (MoM) value to PAPP-A MoM value to delicately categorize FTS results in a way that reduce FNR without imposing unnecessary anxious and extra money on most families. METHODS: The present investigation was conducted retrospectively on 197,210 pregnancies undergoing FTS for aneuploidies in Nilou medical laboratory, Tehran, Iran, from March 2015 to February 2016. RESULTS: Intermediate risk group is important as 23 out of 45 FN fell in the range 1:250 to 1:1100. By applying the proposed index, the ratio of fβ-hCG MoM to PAPP-A MoM and subsequent decision about NIPT, 8 out of 23 FN cases in intermediate group could be detected. CONCLUSION: Compared with the current policy, our novel proposed approach had better performance and could be applied by the Iran National Health Service to improve the screening program guideline.
Keywords: Down syndrome, fβ-hCG, pregnancy-associated plasma protein-A, PAPP-A
DOI: 10.3233/HAB-200408
Journal: Human Antibodies, vol. 28, no. 3, pp. 203-210, 2020
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl